OpenText 拥有数十年的专业经验,可帮助您解锁数据、连接人员和流程,并以信任为 AI 提供动力
以全新方式查看信息
能够理解您的业务、数据和目标的 AI
迎接更快的决策。您安全的 AI 个人助理已准备就绪,随时开始工作
利用生成式 AI 为供应链获取更深入的见解
利用 AI 内容管理和智能 AI 内容助手实现高效工作
实现更快的应用交付、开发和自动化软件测试
提升客户沟通和体验,助力客户成功
让用户、服务代理和 IT 人员能够找到他们所需的答案
以全新方式查看信息
能够理解您的业务、数据和目标的 AI
迎接更快的决策。您安全的 AI 个人助理已准备就绪,随时开始工作
利用生成式 AI 为供应链获取更深入的见解
利用 AI 内容管理和智能 AI 内容助手实现高效工作
实现更快的应用交付、开发和自动化软件测试
提升客户沟通和体验,助力客户成功
让用户、服务代理和 IT 人员能够找到他们所需的答案
一次连接,即可通过安全的 B2B 集成平台触达一切
通过 AI 驱动的 DevOps 自动化、测试和质量,更快地交付更优质的软件
利用令人难忘的客户体验重新构想对话
获得所需的清晰度,以降低 IT 运营的成本和复杂性
利用成熟的 OpenText 信息管理技术构建自定义应用程序
安全信息管理与可信的 AI 相结合
提升数据和 AI 信任度的统一数据框架
在这里,您可以使用数据语言构建、部署和迭代代理
一套用于帮助摄取数据和自动化元数据标记,以推动 AI 发展的工具
一套使治理具有主动性和持久性的服务和 API
专业服务专家助您踏上 AI 之旅
以全新方式查看信息
能够理解您的业务、数据和目标的 AI
迎接更快的决策。您安全的 AI 个人助理已准备就绪,随时开始工作
利用生成式 AI 为供应链获取更深入的见解
利用 AI 内容管理和智能 AI 内容助手实现高效工作
实现更快的应用交付、开发和自动化软件测试
提升客户沟通和体验,助力客户成功
让用户、服务代理和 IT 人员能够找到他们所需的答案
Xellia PharmaceuticalsOpenText Application Quality Management supports digital transformation to deliver life-saving drugs faster by reducing application testing time by 30–40%

Follow strict regulatory application testing guidelines, showing evidence throughout to ensure the test results cannot be manipulated.
As a global pharmaceutical manufacturer, Xellia is under constant scrutiny from regulators. The Food and Drug Administration (FDA) ensures the quality of drug products by carefully monitoring manufacturers’ compliance with its Current Good Manufacturing Practice (cGMP) regulations. The cGMP regulations for drugs make sure that a product is safe for use, and that it has the ingredients and strength it claims to have.
With many applications, such as Oracle ERP modules, quality management, change management, document management, manufacturing, and serialization systems, Xellia managed a paper-based application testing process, as described by Per Bischoff Kristiansen, QA IT Compliance Specialist for Xellia: “Our testing processes are well defined through Standard Operating Procedures, and we have to show physical evidence for every step to prove the integrity and security of our process. We collaborate with sites around the world, and when a test case needs to be signed off by different people, in specific order and all in different locations, you can imagine that this would easily take 2-3 weeks; even longer if there is a delay at some point.”
The process lacked transparency and when defects were identified during the test phases, it was unclear if, how, and when they had been resolved. This all led to delays and often lastminute remediation actions.
Because issues are highlighted earlier in the process, they can be addressed straightaway, resulting in higher quality applications. Even taking into account the initial time investment of having to enter the tests into OpenText™ Application Quality Management, I still estimate a time saving of at least 30–40 percent.
itm8, a Danish IT consultancy firm, is certified in best practice testing methods and tools. It specializes in life sciences and is very familiar with FDA regulations. For Kristiansen, itm8 was the obvious partner to discuss test automation, to increase test quality, accuracy, and efficiency for Xellia. Ole Kramer, Director, Service and Support for itm8 presented their proposed solution: “We recommended OpenText Application Quality Management, which in our view is the mother of all test tools. It is not only a functional test solution, but it encompasses all steps involved in test management, going from requirements, test cases, test execution, defect management, and release management; all working seamlessly together to create a central repository.”
The implementation was done at itm8’s hosting datacentre, and also included Agiliprove, a TechData solution that was integrated with OpenText Application Quality Management. This enables requirements routing, electronic signatures, and the ability to lock test cases once they are completed, to assure FDA inspectors that test results have not been manipulated. Every individual test phase requires approval before the process moves forward. Within three weeks of starting the OpenText Application Quality Management implementation, the system was ready to begin the first test project: the serialization system
We work with project members from various time zones, and with the paper-based system this would always complicate matters. Based on previous experience this test process could take one month. With OpenText Application Quality Management workflows guiding us through the process, we finished it in a week.
The assignment of a unique serial number linked to the individual production data, in conjunction with sealed labels on the packaging ensures the authenticity and integrity of a drug unit and protects against tampering. Kristiansen felt this was a perfect test case for OpenText Application Quality Management: “We work with project members from various time zones, and with the paper-based system this would always complicate matters. Based on previous experience this test process could take a month. With OpenText Application Quality Management workflows guiding us through the process, we finished it in a week.”
Kristiansen notes the improved team collaboration as an unexpected benefit: “We have daily testing meetings, and with everyone working from the same central OpenText Application Quality Management system we can highlight any defects early on in the process. Often defects are corrected there and then in our multidisciplinary meetings, shortening the release cycle and removing communication bottlenecks. Before, it would take days, or even weeks to decide how a defect would be managed.”
OpenText Application Quality Management built-in audit log capabilities track all changes to a specific entity. Kristiansen appreciates this: “We leverage the OpenText Application Quality Management audit trail and plan to use this for periodic review of our computer systems. Depending on the system criticality we are required to formally check our systems and documentation every 1-5 years. With OpenText Application Quality Management we can limit the audit log to just the fields that we need for this activity.”
The benefits of the OpenText Application Quality Management model extrapolate with each new project, as the repository grows. “Because issues are highlighted earlier in the process, they can be addressed straightaway, resulting in higher quality applications”, says Kristiansen. “Even taking into account the initial time investment of having to enter the tests into OpenText Application Quality Management, I still estimate a time saving of at least 30–40 percent.”
He concludes: “Although our paper-based test processes worked, it would be time-intensive to deliver the required information during authority inspections. Now, our transparent system shows our inspectors we are in control of our processes and fully confident in the information we share.”

Xellia Pharmaceuticals is a specialty pharmaceutical company providing important anti-infective treatments against serious and often life-threatening infections. Xellia is wholly owned by Novo Holdings A/S and has state-of-the-art manufacturing facilities located in Denmark, Hungary, China, and the U.S.